Developer docs
API playgroundTry for free, no card

Search company profiles

Pharma Integration

Full company profile

uuid000qd4w

Namestring
Pharma Integration
Legal namestring
Pharma Integration SRL
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Pharma Integration SRL is an Italian privately held engineering company founded in 2016 and headquartered in Siena, within an Italian Pharma Park focused on life sciences. The company designs and manufactures the Azzurra platform — a family of fully robotic, gloveless, and humanless aseptic fill-finish systems (Azzurra Micro for micro-batch production, Azzurra Small for small-batch vials/syringes/cartridges, and Azzurra FAB for campaign-long production in a room isolator). The platform is built on 6-axis Denso robotic arms performing denesting, filling, stoppering, capping and renesting within a monobloc architecture that integrates the isolator, VHP generator, HVAC, and unified control systems into a single factory-assembled, pre-qualified unit, complemented by a proprietary No-Touch-Transfer tub debagging system with a Grade B intermediate zone and UV-C Tyvek decontamination.

Pharma Integration generates revenue primarily through direct enterprise sales of high-value Azzurra capital equipment to pharmaceutical drug-product manufacturers, biotech multiproduct facilities, and emerging cell-and-gene-therapy producers, supplemented by installation/qualification services and recurring consumables from the co-developed BioCapt Single-Use Microbial Impactor AutoM. The go-to-market is consultative field sales supported by ISPE conference participation, technical webinars, and whitepapers. Regulatory positioning is a core pillar: the Azzurra platform is reportedly the first fill-finish system of its kind admitted to both the FDA Emerging Technology Program and the EMA Quality Innovation Group, and the company holds ISO 9001:2015 (Bureau Veritas) and ACCREDIA certifications.

The company is privately held, with ownership concentrated among co-founders Claudio Bechini (Managing Director) and Cinzia Butini (VP of Engineering), together with strategic minority investors PM Group and Euromatic, which provided an undisclosed capital injection in August 2025 to fund Azzurra platform development and international expansion. Operations remain based in Siena, Italy, with stated commercial reach into the United States and broader European Union.

Short descriptiontext

Pharma Integration is an Italian engineering firm that designs and sells the Azzurra platform, a family of fully robotic, gloveless, humanless aseptic fill-finishing systems for pharmaceutical and biotech manufacturers of injectables, advanced biologics, and cell and gene therapies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSiena, Italy
HQ citystring
Siena
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
robotic fill-finishing systems, aseptic pharmaceutical manufacturing, gloveless isolator automation, small volume parenteral equipment, environmental monitoring solutions
Industry2 codes
PRIMARYHLAAAJAD
Process Analytical Technology (PAT) & In-Line/At-Line Analytics (spectroscopy, sensors, monitoring)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAAAJAC
Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
NAICS code2 codes
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Pharmaceutical Manufacturing Equipment
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Robotic Fill-Finish Systems Sales
TypeHardware Sales
Description

Sale of Azzurra platform systems including Azzurra Micro, Azzurra Small, and Azzurra FAB. These are modular, fully robotic, gloveless and humanless fill-finish systems for aseptic processing. Revenue is generated through one-time capital equipment sales with likely professional services for installation and qualification.

pharma-integration.it
2Environmental Monitoring Solutions
TypeHardware Sales
Description

Sale of BioCapt Single-Use Microbial Impactor AutoM for robotic pharmaceutical manufacturing environments. Single-use plates for active microbial air sampling.

pharma-integration.it
3Professional Services
TypeProfessional Services
Description

Installation, qualification, and support services associated with monobloc system deployment. Factory-tested systems reduce on-site CQV burden.

pharma-integration.it
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Azzurra
Description

Family of fully modular, gloveless and humanless, robotic fill-finish systems designed for aseptic processing of small volume parenterals. Includes Azzurra Micro (R&D module for micro-batch), Azzurra Small (four-module solution for small-batch), and Azzurra FAB (miniature room isolator for campaign-long production).

pharma-integration.it
+2 more records
Core offering1 text field

Pharma Integration designs, manufactures, and sells the Azzurra family of fully modular, gloveless, and humanless robotic fill-finish systems for aseptic processing of small-volume parenterals (vials, syringes, cartridges). The monobloc architecture integrates 6-axis robotic arms, isolator, VHP generator, and on-board HVAC into a single factory-tested unit delivered plug-and-play. The company also offers the co-developed BioCapt Single-Use Microbial Impactor AutoM for robotic environmental monitoring.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Downtime between batches: Less than 4 hours
+4 more records
Product overview1 text field

Pharma Integration provides cutting-edge robotic fill-finishing systems for small-volume parenterals and next-generation drugs. The Azzurra platform is a family of three fully modular, gloveless, and humanless robotic fill-finish systems: Azzurra Micro (two-module R&D solution for micro-batch production), Azzurra Small (four-module solution for small-batch production), and Azzurra FAB (miniature room isolator for campaign-long production). All Azzurra systems feature monobloc design integrating robotic process unit, isolator, VHP generator, on-board HVAC, and unified control systems. Complementing the fill-finish portfolio is the BioCapt Single-Use Microbial Impactor AutoM, a co-developed environmental monitoring solution designed for robotic accessibility. The complete portfolio operates on a philosophy of standardization, flexibility, and regulatory alignment with Quality by Design principles.

Product and service4 records
1Azzurra Micro
CategoryRobotic Aseptic Fill-Finish Equipment
Description

A two-robotic-module monobloc aseptic fill-finishing solution designed for micro-batch production, ideal for cell and gene therapies, clinical trials, and personalized medicine manufacturing.

2Azzurra Small
CategoryRobotic Aseptic Fill-Finish Equipment
Description

The first fully robotic monobloc system with four compact robotic modules for small-batch aseptic production, handling vials, syringes and cartridges (RTU and bulk) with any closure type. Achieves downtime between batches under 4 hours and decontamination cycles under 60 minutes.

3Azzurra FAB
CategoryRobotic Aseptic Fill-Finish Equipment
Description

An automated, humanless, and gloveless robotic fill-finish system within an isolated room enclosure, designed for campaign-long production of small-volume parenterals.

4BioCapt Single-Use Microbial Impactor AutoM
CategoryEnvironmental Monitoring Consumables
Description

Single-use plate for active viable air sampling within robotic pharmaceutical manufacturing environments, co-developed with Particle Measuring Systems. Features a magnetic lid design for robotic handling, liquid-tight seal to prevent vapor penetration (VHP), supports up to 4 hours of continuous monitoring, and is compliant with EU GMP Annex 1 and ISO 14698-1.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1ServiTecno
Strategic tierKeyTypeTechnology or IntegrationAnnounced on2024-11-21
Description

Strategic partnership integrating GE Vernova iFIX HMI/SCADA system into Azzurra platforms for real-time data control, intuitive interfaces, and robust cybersecurity. ServiTecno collaboration enables advanced software integration with robotics.

pharma-integration.it
Strategic tierKeyTypeTechnology or IntegrationAnnounced on2024-11-04
Description

Strategic partnership leveraging Siemens industrial PCs and advanced automation controls. Integration of operational technology (OT) with informative technology (IT) achieving high-performance industrial automation within Industry 4.0 and 5.0 environments.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Co-developed the BioCapt Single-Use Microbial Impactor AutoM, a patented robotic-accessible microbial air sampling solution. Two innovative patents resulted from this collaboration. The product is specifically designed for robotic manipulation in pharmaceutical manufacturing environments.

Strategic tierCoreTypeTechnology or Integration
Description

Provider of advanced drive systems for Azzurra robotic automation. Faulhaber motors are renowned for compact size, precision, and exceptional performance, providing the reliability and accuracy needed for pharmaceutical manufacturing.

5Denso
Strategic tierCoreTypeTechnology or Integration
Description

Provider of 6-axis robotic arms used in Azzurra Small system. Denso robots perform critical fill-finishing operations including denesting, filling, stoppering, capping, and renesting within the monobloc system.

pharma-integration.it
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global supplier of bioprocessing and fill-finish equipment for biologics, vaccines and advanced therapies. Competes with Pharma Integration especially in cell/gene therapy and multiproduct flexible manufacturing segments.

TypeBroad incumbent
Description

Italian-headquartered global leader in pharmaceutical processing and packaging machinery, including aseptic fill-finish lines. Competes with Pharma Integration across sterile injectable fill-finish but operates a far broader equipment and services portfolio.

TypeBroad incumbent
Description

Italian-headquartered supplier of glass primary packaging and integrated fill-finish systems for injectable drugs. Both a potential partner and a competitor to Pharma Integration in aseptic processing and turnkey solutions.

TypeDirect peer
Description

German specialist in filling and closing machinery for pharmaceuticals and cosmetics, with deep expertise in aseptic fill-finish for vials, syringes and cartridges — directly comparable to Azzurra Small in target containers and customer segments.

TypeEmerging player
Description

Provider of peristaltic pumps and fluid path components for biopharmaceutical fill-finish applications. Adjacent to Pharma Integration, supplying components into fill-finish lines similar to Azzurra's customers.

TypeRegional player
Description

UK-based manufacturer of sterilization, washing and isolation equipment for pharmaceutical production. Overlaps in aseptic and contamination-control technology adjacent to Pharma Integration's monobloc/isolator approach.

TypeBroad incumbent
Description

Major global supplier of processing and packaging equipment for pharmaceuticals, including robotic and isolator-based aseptic fill-finish systems. Overlaps directly with Azzurra's customer base and use cases.

TypeBroad incumbent
Description

Large industrial conglomerate with a pharmaceutical processing and fill-finish equipment portfolio serving injectable drug manufacturers. Broader scope than Pharma Integration but competes in the same aseptic processing customer set.

TypeBroad incumbent
Description

Global medical device leader whose Pharmaceutical Systems division supplies pre-fillable syringes, vials and combination products, with growing interest in fill-finish equipment and services. Competes in sterile injectable packaging workflows that overlap with Azzurra's RTU syringe and vial use cases.

TypeDirect peer
Description

German specialist in aseptic filling and isolator technology for vials, syringes and cartridges. Directly competes with Pharma Integration for aseptic fill-finish contracts with injectables manufacturers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pharma Integration

Pharmaceutical Manufacturing Equipmentpharma-integration.it

Pharma Integration is an Italian engineering firm that designs and sells the Azzurra platform, a family of fully robotic, gloveless, humanless aseptic fill-finishing systems for pharmaceutical and biotech manufacturers of injectables, advanced biologics, and cell and gene therapies.

What Pharma Integration does

Pharma Integration SRL is an Italian privately held engineering company founded in 2016 and headquartered in Siena, within an Italian Pharma Park focused on life sciences. The company designs and manufactures the Azzurra platform — a family of fully robotic, gloveless, and humanless aseptic fill-finish systems (Azzurra Micro for micro-batch production, Azzurra Small for small-batch vials/syringes/cartridges, and Azzurra FAB for campaign-long production in a room isolator). The platform is built on 6-axis Denso robotic arms performing denesting, filling, stoppering, capping and renesting within a monobloc architecture that integrates the isolator, VHP generator, HVAC, and unified control systems into a single factory-assembled, pre-qualified unit, complemented by a proprietary No-Touch-Transfer tub debagging system with a Grade B intermediate zone and UV-C Tyvek decontamination.

Pharma Integration generates revenue primarily through direct enterprise sales of high-value Azzurra capital equipment to pharmaceutical drug-product manufacturers, biotech multiproduct facilities, and emerging cell-and-gene-therapy producers, supplemented by installation/qualification services and recurring consumables from the co-developed BioCapt Single-Use Microbial Impactor AutoM. The go-to-market is consultative field sales supported by ISPE conference participation, technical webinars, and whitepapers. Regulatory positioning is a core pillar: the Azzurra platform is reportedly the first fill-finish system of its kind admitted to both the FDA Emerging Technology Program and the EMA Quality Innovation Group, and the company holds ISO 9001:2015 (Bureau Veritas) and ACCREDIA certifications.

The company is privately held, with ownership concentrated among co-founders Claudio Bechini (Managing Director) and Cinzia Butini (VP of Engineering), together with strategic minority investors PM Group and Euromatic, which provided an undisclosed capital injection in August 2025 to fund Azzurra platform development and international expansion. Operations remain based in Siena, Italy, with stated commercial reach into the United States and broader European Union.

Pharma Integration firmographics

Firmographics
Name
Pharma Integration
Legal name
Pharma Integration SRL
Website
https://pharma-integration.it
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Pharma Integration is an Italian engineering firm that designs and sells the Azzurra platform, a family of fully robotic, gloveless, humanless aseptic fill-finishing systems for pharmaceutical and biotech manufacturers of injectables, advanced biologics, and cell and gene therapies.
Ownership category
akta.pro rank

Pharma Integration industry classification

Industry
Product category
Pharmaceutical Manufacturing Equipment
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAAAJAD
Process Analytical Technology (PAT) & In-Line/At-Line Analytics (spectroscopy, sensors, monitoring)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAAAJAC
Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)

Keywords

  • Robotic fill-finishing systems
  • Aseptic pharmaceutical manufacturing
  • Gloveless isolator automation
  • Small volume parenteral equipment
  • Environmental monitoring solutions

Where Pharma Integration is headquartered

Location

Headquarters

HQ city
Siena
HQ country
Italy
HQ region
Europe

Offices1 record

Markets served

Pharma Integration business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Robotic Fill-Finish Systems Sales: Sale of Azzurra platform systems including Azzurra Micro, Azzurra Small, and Azzurra FAB. These are modular, fully robotic, gloveless and humanless fill-finish systems for aseptic processing. Revenue is generated through one-time capital equipment sales with likely professional services for installation and qualification.
  2. Environmental Monitoring Solutions: Sale of BioCapt Single-Use Microbial Impactor AutoM for robotic pharmaceutical manufacturing environments. Single-use plates for active microbial air sampling.
  3. Professional Services: Installation, qualification, and support services associated with monobloc system deployment. Factory-tested systems reduce on-site CQV burden.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Pharma Integration product offering

Product offering

Core offering

Pharma Integration designs, manufactures, and sells the Azzurra family of fully modular, gloveless, and humanless robotic fill-finish systems for aseptic processing of small-volume parenterals (vials, syringes, cartridges). The monobloc architecture integrates 6-axis robotic arms, isolator, VHP generator, and on-board HVAC into a single factory-tested unit delivered plug-and-play. The company also offers the co-developed BioCapt Single-Use Microbial Impactor AutoM for robotic environmental monitoring.

Product overview

Pharma Integration provides cutting-edge robotic fill-finishing systems for small-volume parenterals and next-generation drugs. The Azzurra platform is a family of three fully modular, gloveless, and humanless robotic fill-finish systems: Azzurra Micro (two-module R&D solution for micro-batch production), Azzurra Small (four-module solution for small-batch production), and Azzurra FAB (miniature room isolator for campaign-long production). All Azzurra systems feature monobloc design integrating robotic process unit, isolator, VHP generator, on-board HVAC, and unified control systems. Complementing the fill-finish portfolio is the BioCapt Single-Use Microbial Impactor AutoM, a co-developed environmental monitoring solution designed for robotic accessibility. The complete portfolio operates on a philosophy of standardization, flexibility, and regulatory alignment with Quality by Design principles.

Differentiator

Problem solved

Functional benefit

Brands

  • Azzurra: Family of fully modular, gloveless and humanless, robotic fill-finish systems designed for aseptic processing of small volume parenterals. Includes Azzurra Micro (R&D module for micro-batch), Azzurra Small (four-module solution for small-batch), and Azzurra FAB (miniature room isolator for campaign-long production).
  • BioCapt Single-Use Microbial Impactor AutoM
  • BCSU AutoM

Products and services

  • Azzurra Micro A two-robotic-module monobloc aseptic fill-finishing solution designed for micro-batch production, ideal for cell and gene therapies, clinical trials, and personalized medicine manufacturing.
  • Azzurra Small The first fully robotic monobloc system with four compact robotic modules for small-batch aseptic production, handling vials, syringes and cartridges (RTU and bulk) with any closure type. Achieves downtime between batches under 4 hours and decontamination cycles under 60 minutes.
  • Azzurra FAB An automated, humanless, and gloveless robotic fill-finish system within an isolated room enclosure, designed for campaign-long production of small-volume parenterals.
  • BioCapt Single-Use Microbial Impactor AutoM Single-use plate for active viable air sampling within robotic pharmaceutical manufacturing environments, co-developed with Particle Measuring Systems. Features a magnetic lid design for robotic handling, liquid-tight seal to prevent vapor penetration (VHP), supports up to 4 hours of continuous monitoring, and is compliant with EU GMP Annex 1 and ISO 14698-1.

Quantifiable outcome

  • Downtime between batches: Less than 4 hours
  • +4 more outcomes

Companies that use Pharma Integration

Customer profile

Segments3 records

Ideal customer profiles2 records

Pharma Integration technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature7 records

Pharma Integration partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered key and core.

  • ServiTecnokeyTechnology or Integration · 21 November 2024Strategic partnership integrating GE Vernova iFIX HMI/SCADA system into Azzurra platforms for real-time data control, intuitive interfaces, and robust cybersecurity. ServiTecno collaboration enables advanced software integration with robotics.
  • SiemenskeyTechnology or Integration · 4 November 2024Strategic partnership leveraging Siemens industrial PCs and advanced automation controls. Integration of operational technology (OT) with informative technology (IT) achieving high-performance industrial automation within Industry 4.0 and 5.0 environments.
  • Particle Measuring SystemscoreStrategic or Co-development PartnerCo-developed the BioCapt Single-Use Microbial Impactor AutoM, a patented robotic-accessible microbial air sampling solution. Two innovative patents resulted from this collaboration. The product is specifically designed for robotic manipulation in pharmaceutical manufacturing environments.
  • FaulhabercoreTechnology or IntegrationProvider of advanced drive systems for Azzurra robotic automation. Faulhaber motors are renowned for compact size, precision, and exceptional performance, providing the reliability and accuracy needed for pharmaceutical manufacturing.
  • DensocoreTechnology or IntegrationProvider of 6-axis robotic arms used in Azzurra Small system. Denso robots perform critical fill-finishing operations including denesting, filling, stoppering, capping, and renesting within the monobloc system.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Pharma Integration competitors and assessment

Company assessment

Broad incumbents

  • Cytiva (formerly GE Healthcare Life Sciences): Global supplier of bioprocessing and fill-finish equipment for biologics, vaccines and advanced therapies. Competes with Pharma Integration especially in cell/gene therapy and multiproduct flexible manufacturing segments.
  • IMA S.p.A. Italian-headquartered global leader in pharmaceutical processing and packaging machinery, including aseptic fill-finish lines. Competes with Pharma Integration across sterile injectable fill-finish but operates a far broader equipment and services portfolio.
  • Stevanato Group: Italian-headquartered supplier of glass primary packaging and integrated fill-finish systems for injectable drugs. Both a potential partner and a competitor to Pharma Integration in aseptic processing and turnkey solutions.
  • Syntegon Technology (formerly Bosch Packaging Technology): Major global supplier of processing and packaging equipment for pharmaceuticals, including robotic and isolator-based aseptic fill-finish systems. Overlaps directly with Azzurra's customer base and use cases.
  • GEA Group (Pharma Spray Dryers & Containment): Large industrial conglomerate with a pharmaceutical processing and fill-finish equipment portfolio serving injectable drug manufacturers. Broader scope than Pharma Integration but competes in the same aseptic processing customer set.
  • Becton, Dickinson and Company (BD) — Pharmaceutical Systems: Global medical device leader whose Pharmaceutical Systems division supplies pre-fillable syringes, vials and combination products, with growing interest in fill-finish equipment and services. Competes in sterile injectable packaging workflows that overlap with Azzurra's RTU syringe and vial use cases.

Direct peers

  • Groninger & Co. GmbH: German specialist in filling and closing machinery for pharmaceuticals and cosmetics, with deep expertise in aseptic fill-finish for vials, syringes and cartridges — directly comparable to Azzurra Small in target containers and customer segments.
  • Optima Pharma GmbH: German specialist in aseptic filling and isolator technology for vials, syringes and cartridges. Directly competes with Pharma Integration for aseptic fill-finish contracts with injectables manufacturers.

Emerging players

  • Watson-Marlow (Spirax-Sarco): Provider of peristaltic pumps and fluid path components for biopharmaceutical fill-finish applications. Adjacent to Pharma Integration, supplying components into fill-finish lines similar to Azzurra's customers.

Regional players

  • Astell Scientific: UK-based manufacturer of sterilization, washing and isolation equipment for pharmaceutical production. Overlaps in aseptic and contamination-control technology adjacent to Pharma Integration's monobloc/isolator approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Pharma Integration social profiles

Digital presence

Pharma Integration compliance and trust

Trust signal

Compliance5 records

Pharma Integration financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pharma Integration leadership team

Management profile

Number of profiles

Profiles3 records

Pharma Integration funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pharma Integration M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma Integration

What does Pharma Integration do?

Pharma Integration designs, manufactures, and sells the Azzurra family of fully modular, gloveless, and humanless robotic fill-finish systems for aseptic processing of small-volume parenterals (vials, syringes, cartridges). The monobloc architecture integrates 6-axis robotic arms, isolator, VHP generator, and on-board HVAC into a single factory-tested unit delivered plug-and-play. The company also offers the co-developed BioCapt Single-Use Microbial Impactor AutoM for robotic environmental monitoring.

Is Pharma Integration a public or private company?

Pharma Integration is a private company. It is classified as venture growth investor backed and is currently operating.

When was Pharma Integration founded?

Pharma Integration was founded in 2016. It employs 11 to 50 people.

Where is Pharma Integration based?

Pharma Integration is headquartered in Siena, Italy, in the Europe region.

How does Pharma Integration make money?

Three revenue lines are on record. Robotic Fill-Finish Systems Sales are the primary driver. The others are environmental Monitoring Solutions and professional Services.

Who are Pharma Integration's main competitors?

Broad incumbents on record are Cytiva (formerly GE Healthcare Life Sciences), IMA S.p.A., Stevanato Group, Syntegon Technology (formerly Bosch Packaging Technology), GEA Group (Pharma Spray Dryers & Containment) and Becton, Dickinson and Company (BD) — Pharmaceutical Systems. Direct peers are Groninger & Co. GmbH and Optima Pharma GmbH. Watson-Marlow (Spirax-Sarco) is listed as an emerging player. Astell Scientific is listed as a regional player.

Does Pharma Integration have an API?

No public API is recorded for Pharma Integration.

What industry is Pharma Integration in?

Pharma Integration's product category is Pharmaceutical Manufacturing Equipment. Its primary akta.pro industry code is HLAAAJAD, Process Analytical Technology (PAT) & In-Line/At-Line Analytics (spectroscopy, sensors, monitoring), with a secondary code of HLAAAJAC, Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors). Its NAICS code is 3345 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales